380 related articles for article (PubMed ID: 24744204)
1. FTY720 protects retinal ganglion cells in experimental glaucoma.
You Y; Gupta VK; Li JC; Al-Adawy N; Klistorner A; Graham SL
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3060-6. PubMed ID: 24744204
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of FTY720 against sevoflurane-induced developmental neurotoxicity in rats.
Zhou H; Li S; Niu X; Wang P; Wang J; Zhang M
Cell Biochem Biophys; 2013 Nov; 67(2):591-8. PubMed ID: 23471662
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina.
Shima C; Adachi Y; Minamino K; Okigaki M; Shi M; Imai Y; Yanai S; Takahashi K; Ikehara S
Ophthalmic Res; 2012; 48(4):199-207. PubMed ID: 22868688
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
5. The S1P1 receptor-selective agonist CYM-5442 protects retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss.
Blanco R; Martínez-Navarrete G; Valiente-Soriano FJ; Avilés-Trigueros M; Pérez-Rico C; Serrano-Puebla A; Boya P; Fernández E; Vidal-Sanz M; de la Villa P
Exp Eye Res; 2017 Nov; 164():37-45. PubMed ID: 28827028
[TBL] [Abstract][Full Text] [Related]
6. Protection of retinal ganglion cells and the optic nerve during short-term hyperglycemia in experimental glaucoma.
Ebneter A; Chidlow G; Wood JP; Casson RJ
Arch Ophthalmol; 2011 Oct; 129(10):1337-44. PubMed ID: 21987677
[TBL] [Abstract][Full Text] [Related]
7. Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats.
Hasegawa Y; Suzuki H; Sozen T; Rolland W; Zhang JH
Stroke; 2010 Feb; 41(2):368-74. PubMed ID: 19940275
[TBL] [Abstract][Full Text] [Related]
8. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
Mammone T; Chidlow G; Casson RJ; Wood JPM
Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
[TBL] [Abstract][Full Text] [Related]
9. Valproate promotes survival of retinal ganglion cells in a rat model of optic nerve crush.
Zhang ZZ; Gong YY; Shi YH; Zhang W; Qin XH; Wu XW
Neuroscience; 2012 Nov; 224():282-93. PubMed ID: 22867974
[TBL] [Abstract][Full Text] [Related]
10. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
[TBL] [Abstract][Full Text] [Related]
11. Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors.
Cui QL; Fang J; Kennedy TE; Almazan G; Antel JP
Glia; 2014 Aug; 62(8):1361-75. PubMed ID: 24810969
[TBL] [Abstract][Full Text] [Related]
12. Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas.
Vidal-Sanz M; Salinas-Navarro M; Nadal-Nicolás FM; Alarcón-Martínez L; Valiente-Soriano FJ; de Imperial JM; Avilés-Trigueros M; Agudo-Barriuso M; Villegas-Pérez MP
Prog Retin Eye Res; 2012 Jan; 31(1):1-27. PubMed ID: 21946033
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
14. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma.
Levkovitch-Verbin H; Quigley HA; Martin KR; Harizman N; Valenta DF; Pease ME; Melamed S
Exp Eye Res; 2005 May; 80(5):663-70. PubMed ID: 15862173
[TBL] [Abstract][Full Text] [Related]
15. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model.
Abdul Y; Akhter N; Husain S
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):1816-28. PubMed ID: 23404122
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures.
Hare WA; WoldeMussie E; Weinreb RN; Ton H; Ruiz G; Wijono M; Feldmann B; Zangwill L; Wheeler L
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2640-51. PubMed ID: 15277487
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.
Huang S; Huang P; Lin Z; Liu X; Xu X; Guo L; Shen X; Li C; Zhong Y
Exp Eye Res; 2018 Mar; 168():33-48. PubMed ID: 29326065
[TBL] [Abstract][Full Text] [Related]
18. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of phosphatidylinositol 3-kinase/akt pathway in retinal ganglion cell survival in rats with or without acute ocular hypertension.
Huang Y; Cen LP; Luo JM; Wang N; Zhang MZ; van Rooijen N; Pang CP; Cui Q
Neuroscience; 2008 Apr; 153(1):214-25. PubMed ID: 18358617
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted antioxidant peptide SS-31 mediates neuroprotection in a rat experimental glaucoma model.
Wu X; Pang Y; Zhang Z; Li X; Wang C; Lei Y; Li A; Yu L; Ye J
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):411-421. PubMed ID: 30811524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
